Chemical modification of hyaluronic acid for intraoral application

Journal of Pharmaceutical Sciences

Volumn 103, Issue 8, 2014, Pages 2414-2423

  Laffleur, Flavia ^a   Röggla, Julia ^a   Idrees, Muneeb Ahmad ^a   Griessinger, Julia ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Thiomatrix Forschungs und Beratungs GmbH   (Austria)

Author keywords

biomaterials; buccal; hyaluronic acid; intraoral application; mercaptonicotinamide; mucosal delivery; polymeric drug carrier; polymers; preactivated thiomers; thiomers

Indexed keywords

6 MERCAPTONICOTINAMIDE; BIOMATERIAL; DIMER; DRUG CARRIER; HYALURONIC ACID; LACTATE DEHYDROGENASE; MONOMER; POLYMER; PREACTIVATED THIOMER; THIOL DERIVATIVE; THIOMER; UNCLASSIFIED DRUG; CYSTEINE; NICOTINAMIDE;

ADHESION; ARTICLE; CACO 2 CELL LINE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG DELIVERY SYSTEM; ENZYME ASSAY; HUMAN; HUMAN CELL; MOUTH MUCOSA; PROTON NUCLEAR MAGNETIC RESONANCE; SHEAR STRENGTH; SYNTHESIS; ULTRAVIOLET SPECTROPHOTOMETRY; ANALOGS AND DERIVATIVES; CHEMISTRY; METABOLISM;

CACO-2 CELLS; CYSTEINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; MOUTH MUCOSA; NIACINAMIDE; POLYMERS; SULFHYDRYL COMPOUNDS;

EID: 84905106751     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24060     Document Type: Article

References (37)

1. Bernkop-Schnurch A, Walker G,. 2001. Multifunctional matrices for oral peptide delivery. Crit Rev Ther Drug Carrier Syst 18 (5): 459-501.
2. Laffleur F, Bernkop-Schnurch A,. 2012. Thiomers: Promising platform for macromolecular drug delivery. Future Med Chem 4 (17): 2205-2216.
3. Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, Perera G, Schlocker W, Dünnhaput S, Augustijns P, Bernkop-Schnürch A,. 2012. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: Bioavailability and pharmacokinetic characterization. Int J Pharm 428 (1-2): 164-170.
4. Bernkop-Schnurch A,. 2000. The use of multifunctional polymers for non-invasive peptide and protein application. Expert Opin Ther Patents 10 (9): 1357-1366.
5. Hintzen F, Laffleur F, Sakloetsakun D, Leithner K, Bernkop-Schnürch A,. 2012. In situ gelling properties of anionic thiomers. Drug Dev Ind Pharm 38 (12): 1479-1485.
6. Foger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A, 2006. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. Biomaterials 27 (34): 5855-5860.
7. Rahmat D, Müller C, Shahnaz G, Leithner K, Laffleur F, Khan MI, Martien R, Bernkop Schnürch A, 2013. HEC-cysteamine particles: Influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties. Drug Dev Ind Pharm 39 (9): 1338-1345.
8. Wang XQ, Iqbal J, Rahmat D, Bernkop-Schnürch A,. 2012. Preactivated thiomers: Permeation enhancing properties. Int J Pharm 438 (1-2): 217-224.
9. Iqbal J, Shahnaz G, Dünnhaupt S, Müller C, Hintzen F, Bernkop-Schnürch A,. 2012. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials 33 (5): 1528-1535.
10. Laurent TC, Fraser JR,. 1992. Hyaluronan. FASEB J 6 (7): 2397-2404.
11. Li X, Yu G, Jin K, Yin Z,. 2012. Hyaluronic acid L-cysteine conjugate exhibits controlled-release potential for mucoadhesive drug delivery. Die Pharmazie 67 (3): 224-228.
12. Kafedjiiski K, Jetti RK, Föger F, Hoyer H, Werle M, Hoffer M, Bernkop-Schnürch A,. 2007. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery. Int J Pharm 343 (1-2): 48-58.
13. Laffleur F, Shahnaz G, Islambulchilar Z, Bernkop-Schnürch A,. 2013. Design and in vitro evaluation of a novel polymeric excipient for buccal applications. Future Med Chem 5 (5): 511-522.
14. Dunnhaupt S, Barthelmes J, Thurner CC, Waldner C, Sakloetsakun D, Bernkop-Schnürch A,. 2012. S-protected thiolated chitosan: Synthesis and in vitro characterization. Carbohydr Polym 90 (2): 765-772.
15. Bernkop-Schnurch A, Kast CE, Richter MF,. 2001. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 71 (3): 277-285.
16. Bernkop-Schnurch A, Steininger A,. 2000. Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm 194 (2): 239-247.
17. Dunnhaupt S, Barthelmes J, Rahmat D, Leithner K, Thurner CC, Friedl H, Bernkop-Schnürch A,. 2012. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: Evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm 9 (5): 1331-1341.
18. Hind AR, Bhargava SK, McKinnon A,. 2001. At the solid/liquid interface: FTIR/ATR-The tool of choice. Adv Colloid Interface Sci 93 (1-3): 91-114.
19. Santner T, Hartl M, Bister K, Micura R,. 2014. Efficient access to 3′-terminal azide-modified RNA for inverse click-labeling patterns. Bioconjug Chem 25 (1): 188-195.
20. Shahnaz G, Iqbal J, Rahmat D, Perera G, Laffleur F, Rossi D, Bernkop-Schnürch A,. 2012. Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half life. J Control Release 157 (3): 375-382.
21. Jennings P, Koppelstaetter C, Pfaller W, Morin JP, Hartung T, Ryan MP,. 2004. Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: Toxicological evaluation. ALTEX 21 (2): 61-66.
22. Rahmat D, Sakloetsakun D, Shahnaz G, Sarti F, Laffleur F, Schnürch AB,. 2012. HEC-cysteamine conjugates: Influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties. Int J Pharm 422 (1-2): 40-46.
23. Schmitz T, Hombach J, Bernkop-Schnurch A,. 2008. Chitosan-N-acetyl cysteine conjugates: In vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties. Drug Deliv 15 (4): 245-252.
24. Peh KK, Wong CF,. 1999. Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci 2 (2): 53-61.
25. Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A,. 2006. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate. Biomaterials 27 (1): 127-135.
26. Bernkop-Schnurch A,. 2005. Mucoadhesive polymers: Strategies, achievements and future challenges. Adv Drug Deliv Rev 57 (11): 1553-1555.
27. Prajapati SK, Tripathi P, Ubaidulla U, Anand V,. 2008. Design and development of gliclazide mucoadhesive microcapsules: In vitro and in vivo evaluation. AAPS Pharm 9 (1): 224-230.
28. Katona TR,. 1997. A comparison of the stresses developed in tension, shear peel, and torsion strength testing of direct bonded orthodontic brackets. Am J Orthod Dentofacial Orthop 112 (3): 244-251.
29. Metia PK, Bandyopadhyay AK,. 2008. In vitro evaluation of novel mucoadhesive buccal tablet of oxytocin prepared with Diospyros peregrina fruit mucilages. Yakugaku Zasshi 128 (4): 603-609.
30. Bernkop-Schnurch A, König V, Leitner VM, Krauland AH, Brodnik I,. 2004. Preparation and characterisation of thiolated poly(methacrylic acid)-starch compositions. Eur J Pharm Biopharm 57 (2): 219-224.
31. Forrest HS, Walker J,. 1948. Chemotherapeutic agents of the sulphone type; 2: 5-disubstituted derivatives of pyridine. J Chem Soc 70: 1939-1945.
32. Barrett WC, DeGnore JP, König S, Fales HM, Keng YF, Zhang ZY, Yim MB, Chock PB,. 1999. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38 (20): 6699-6705.
33. Mortazavi SA, Smart JD,. 1993. An Investigation into the role of water-movement and mucus gel dehydration in mucoadhesion. J Control Release 25 (3): 197-203.
34. Duchene D, Ponchel G,. 1992. Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials 13 (10): 709-714.
35. Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A,. 2006. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate. Biomaterials 27 (1): 127-135.
36. Salamat-Miller N, Chittchang M, Johnston TP,. 2005. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 57 (11): 1666-1691.
37. Shinkar DM, Dhake AS, Setty CM,. 2012. Drug delivery from the oral cavity: A focus on mucoadhesive buccal drug delivery systems. PDA J Pharm Sci Technol 66 (5): 466-500.